Table of Content


Introduction
Dyslipidemia - Overview
Dyslipidemia - Therapeutics Development
Dyslipidemia - Therapeutics Assessment
Dyslipidemia - Companies Involved in Therapeutics Development
Dyslipidemia - Drug Profiles
Dyslipidemia - Dormant Projects
Dyslipidemia - Discontinued Products
Dyslipidemia - Product Development Milestones
Appendix



List of Figures

List of Figures
Number of Products under Development for Dyslipidemia, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Top 10 Molecule Types, 2021
Number of Products by Stage and Top 10 Molecule Types, 2021

List of Tables

List of Tables
Number of Products under Development for Dyslipidemia, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Dyslipidemia - Pipeline by 89bio Inc, 2021
Dyslipidemia - Pipeline by ABIONYX Pharma SA, 2021
Dyslipidemia - Pipeline by AD Pharmaceuticals Co Ltd, 2021
Dyslipidemia - Pipeline by Addpharma Inc, 2021
Dyslipidemia - Pipeline by Affina Biotechnologies Inc, 2021
Dyslipidemia - Pipeline by Afimmune Biopharma Ltd, 2021
Dyslipidemia - Pipeline by Akcea Therapeutics Inc, 2021
Dyslipidemia - Pipeline by Amarin Corp Plc, 2021
Dyslipidemia - Pipeline by Arrakis Therapeutics Inc, 2021
Dyslipidemia - Pipeline by Arrowhead Pharmaceuticals Inc, 2021
Dyslipidemia - Pipeline by AstraZeneca Plc, 2021
Dyslipidemia - Pipeline by AVVA Pharmaceuticals AG, 2021
Dyslipidemia - Pipeline by Bio-Thera Solutions Ltd, 2021
Dyslipidemia - Pipeline by BioRestorative Therapies Inc, 2021
Dyslipidemia - Pipeline by Boryung Pharmaceutical Co Ltd, 2021
Dyslipidemia - Pipeline by Cadila Healthcare Ltd, 2021
Dyslipidemia - Pipeline by Cardax Inc, 2021
Dyslipidemia - Pipeline by Celltrion Inc, 2021
Dyslipidemia - Pipeline by Celon Pharma SA, 2021
Dyslipidemia - Pipeline by Centaurus Therapeutics Inc, 2021
Dyslipidemia - Pipeline by Centeer BioTherapeutics Ltd Co, 2021
Dyslipidemia - Pipeline by Chong Kun Dang Holdings Corp, 2021
Dyslipidemia - Pipeline by CMG Pharmaceutical Co Ltd, 2021
Dyslipidemia - Pipeline by Corvidia Therapeutics Inc, 2021
Dyslipidemia - Pipeline by CVI Pharmaceuticals US Inc, 2021
Dyslipidemia - Pipeline by Daewon Pharmaceutical Co Ltd, 2021
Dyslipidemia - Pipeline by Daewoong Pharmaceutical Co Ltd, 2021
Dyslipidemia - Pipeline by Daiichi Sankyo Co Ltd, 2021
Dyslipidemia - Pipeline by Delivra Corp, 2021
Dyslipidemia - Dormant Projects, 2021
Dyslipidemia - Discontinued Products, 2021